search
Back to results

Impact of Text Messages to Promote Secondary Prevention After Acute Coronary Syndrome (IMPACS)

Primary Purpose

Cardiovascular Disease

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Mobile phone text message
Sponsored by
Federal University of Minas Gerais
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cardiovascular Disease focused on measuring Acute Coronary Syndrome, Text Messaging, Risk Factors

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Consecutive patients who have been hospitalized at the UFMG's University Hospital with primary or secondary diagnosis of Acute Coronary Syndrome and are discharged for outpatient follow-up;
  • Age ≥ 18 years, of both sexes;
  • Patients who are able to receive text messages by their own mobile phone.

Exclusion Criteria:

  • Refusal or inability to sign the Informed Consent.
  • Complete illiteracy.

Sites / Locations

  • Luiz Guilherme PassagliaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Experimental

No Intervention

Arm Description

Automated semi-personalized mobile phone text message-based intervention for secondary prevention plus usual care.

Usual Care

Outcomes

Primary Outcome Measures

Escore of combined risk factor control
The proportion achieving guideline levels of modifiable risk factors (LDL-C <77mg/dL, blood pressure <140/90 mm Hg, exercising regularly [≥5 d/wk × 30minutes of moderate exercise per session], nonsmoker status, and BMI <25). We prespecified in the statistical analysis plan the efficacy variable of proportion achieving combined risk factor control (achieving risk factor targets in 4 or more of the 5 modifiable risk factors listed above) as a measure of a multiple risk factor effect

Secondary Outcome Measures

Plasma LDL-C level
Fasting blood sample
Level of physical activity (measured via
Measured by research blinded to treatment allocation - The level of physical activity will be mensured by the International Physical Activity Questionnaire Short Form (IPAQ-SF) and it will be validated in one-fifth of the participants by using accelerometers
Blood Pressure
Measured by research blinded to treatment allocation - 3 resting, sitting digital recordings, mean of last 2 readings
Proportion of non-smokers
Measured by research blinded to treatment allocation - Self-reported smoking / quitting attempts will be confirmed with a Carbon Monoxide Meter Breath Test
Body mass index (BMI)
Measured by research blinded to treatment allocation
Medication adherence (measured via "Medida de adesão aos tratamentos" - MAT)
Measured by research blinded to treatment allocation It is an instrument composed of seven items that evaluate the behavior of the individual in relation to daily use of medicines. The answers are obtained by means of a six-point ordinal scale that varies from always (1) to never (6). The values obtained with the answers to the seven items are summed and divided by the number of items (values vary from 1 to 6). Subsequently, values 5 and 6 are computed as one (adherent) and the others are computed as zero (non-adherent).
Death from any cause
Medical records and database
Rehospitalization
Self-report, medical records and database
Cardiovascular death
Medical records and database

Full Information

First Posted
January 14, 2018
Last Updated
May 8, 2018
Sponsor
Federal University of Minas Gerais
search

1. Study Identification

Unique Protocol Identification Number
NCT03414190
Brief Title
Impact of Text Messages to Promote Secondary Prevention After Acute Coronary Syndrome
Acronym
IMPACS
Official Title
Impact of a Mobile Phone Text Messages Intervention on the Secondary Prevention of Cardiovascular Events After Acute Coronary Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
May 2018
Overall Recruitment Status
Unknown status
Study Start Date
November 29, 2017 (Actual)
Primary Completion Date
May 2019 (Anticipated)
Study Completion Date
November 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of Minas Gerais

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study is a two-arm, parallel, randomized clinical trial. The purpose of the study is to evaluate the effectiveness of automated mobile phone text message-based intervention for secondary prevention after acute coronary syndrome hospitalization. Text messages will include information about lifestyle modifications, medication adherence and cardiovascular risk factor control. The participants will be randomized into intervention and control groups in a 1:1 ratio. The intervention group will receive 4 pre-designed and semi-personalized text messages per week in addition to usual care for 6 months, while the control group will receive usual care.
Detailed Description
Purpose of the trial: The purpose of the study is to evaluate the effectiveness of automated mobile phone text message-based intervention for secondary prevention after acute coronary syndrome hospitalization. Trial design: Two-parallel arm, single-blind, block randomization. Primary endpoint: The proportion achieving guideline levels of modifiable risk factors (LDL-C <70mg/dL, blood pressure <140/90 mm Hg, exercising regularly [≥5 d/wk × 30minutes of moderate exercise per session], nonsmoker status, and BMI <25). The investigators prespecified in the statistical analysis plan the efficacy variable of proportion achieving combined risk factor control (achieving risk factor targets in 4 or more of the 5 modifiable risk factors listed above) as a measure of a multiple risk factor effect. Secondary endpoints: The plasma LDL-C level at 6 months, Level of physical activity, Blood Pressure, Medication adherence measured via Morisky scale, Proportion of non-smokers, Body mass index (BMI), Rates death and hospitalization up to 6 months. Duration of follow-up: 6 months Trial treatment: Intervention: The treatment group will receive the usual discharge treatment, instructions and information for acute coronary syndrome patients as well as the text-messaging intervention. The program will include a variety of topics such as standard follow-up care reminders as well as general self-management and healthy living habits texts. There will be four streams: one for patients who are non-smokers and are free of diabetes; one for current/recent smokers; one for diabetic patients; and one for smoker and diabetic patients. Texts will be sent out 4 times per week for 180 days. All participants in the same stream will receive the same texts in the same order. Control: The usual care group will receive standard discharge treatment, instructions, and information for patients with acute coronary syndrome. The participants will also receive SMS thanking for their participation in the trial, reminders of trial appointment and informing if they have changed contact details. The frequency of this SMS will be monthly. Expected sample size, enrollment and expected number of centers: Sample size = 160 Recruitment start date: November, 2017 Recruitment end date: May, 2019 Follow-up end date: November, 2019 Number of centers: 1 Statistical considerations: Intention to treat analysis The trial has >90% power (2 sided alpha = 0.05) to detect 15% difference in achieving risk factor targets in 4 or more of the 5 modifiable risk factors listed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Disease
Keywords
Acute Coronary Syndrome, Text Messaging, Risk Factors

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
160 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental
Arm Type
Experimental
Arm Description
Automated semi-personalized mobile phone text message-based intervention for secondary prevention plus usual care.
Arm Title
No Intervention
Arm Type
No Intervention
Arm Description
Usual Care
Intervention Type
Behavioral
Intervention Name(s)
Mobile phone text message
Intervention Description
The treatment group will receive the usual discharge treatment, instructions and information for acute coronary syndrome patients as well as the text-messaging intervention. The program will include a variety of topics such as standard follow-up care reminders as well as general self-management and healthy living habits texts. There will be four streams: one for patients who are non-smokers and are free of diabetes; one for current/recent smokers; one for diabetic patients; and one for smoker and diabetic patients. Texts will be sent out 4 times per week for 180 days. All participants in the same stream will receive the same texts in the same order. The usual care group will receive standard discharge treatment, instructions, and information for patients with acute coronary syndrome. They will also receive simple and short text messages related to the importance of trial participation.
Primary Outcome Measure Information:
Title
Escore of combined risk factor control
Description
The proportion achieving guideline levels of modifiable risk factors (LDL-C <77mg/dL, blood pressure <140/90 mm Hg, exercising regularly [≥5 d/wk × 30minutes of moderate exercise per session], nonsmoker status, and BMI <25). We prespecified in the statistical analysis plan the efficacy variable of proportion achieving combined risk factor control (achieving risk factor targets in 4 or more of the 5 modifiable risk factors listed above) as a measure of a multiple risk factor effect
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Plasma LDL-C level
Description
Fasting blood sample
Time Frame
6 months
Title
Level of physical activity (measured via
Description
Measured by research blinded to treatment allocation - The level of physical activity will be mensured by the International Physical Activity Questionnaire Short Form (IPAQ-SF) and it will be validated in one-fifth of the participants by using accelerometers
Time Frame
6 months
Title
Blood Pressure
Description
Measured by research blinded to treatment allocation - 3 resting, sitting digital recordings, mean of last 2 readings
Time Frame
6 months
Title
Proportion of non-smokers
Description
Measured by research blinded to treatment allocation - Self-reported smoking / quitting attempts will be confirmed with a Carbon Monoxide Meter Breath Test
Time Frame
6 months
Title
Body mass index (BMI)
Description
Measured by research blinded to treatment allocation
Time Frame
6 months
Title
Medication adherence (measured via "Medida de adesão aos tratamentos" - MAT)
Description
Measured by research blinded to treatment allocation It is an instrument composed of seven items that evaluate the behavior of the individual in relation to daily use of medicines. The answers are obtained by means of a six-point ordinal scale that varies from always (1) to never (6). The values obtained with the answers to the seven items are summed and divided by the number of items (values vary from 1 to 6). Subsequently, values 5 and 6 are computed as one (adherent) and the others are computed as zero (non-adherent).
Time Frame
6 months
Title
Death from any cause
Description
Medical records and database
Time Frame
6 months
Title
Rehospitalization
Description
Self-report, medical records and database
Time Frame
6 months
Title
Cardiovascular death
Description
Medical records and database
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Consecutive patients who have been hospitalized at the UFMG's University Hospital with primary or secondary diagnosis of Acute Coronary Syndrome and are discharged for outpatient follow-up; Age ≥ 18 years, of both sexes; Patients who are able to receive text messages by their own mobile phone. Exclusion Criteria: Refusal or inability to sign the Informed Consent. Complete illiteracy.
Facility Information:
Facility Name
Luiz Guilherme Passaglia
City
Belo Horizonte
State/Province
MG
ZIP/Postal Code
30575210
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luiz G Passaglia, master's
Phone
3199038674
Email
lg.passaglia@uol.com.br
First Name & Middle Initial & Last Name & Degree
Luiz G Passaglia, M.D.
First Name & Middle Initial & Last Name & Degree
Antônio LP Ribeiro, M.D., Ph.D
First Name & Middle Initial & Last Name & Degree
Luisa CC Brant, M.D., Ph.D
First Name & Middle Initial & Last Name & Degree
Bruno R Nascimento, M.D., Ph.D.

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Impact of Text Messages to Promote Secondary Prevention After Acute Coronary Syndrome

We'll reach out to this number within 24 hrs